Amneal Pfcf Ratio from 2010 to 2025

AMRX Stock  USD 8.58  0.32  3.87%   
Amneal Pharmaceuticals, PFCF Ratio yearly trend continues to be fairly stable with very little volatility. PFCF Ratio is likely to outpace its year average in 2025. During the period from 2010 to 2025, Amneal Pharmaceuticals, PFCF Ratio regression line of annual values had significance of  0.000017 and arithmetic mean of (250.87). View All Fundamentals
 
PFCF Ratio  
First Reported
2010-12-31
Previous Quarter
3.46
Current Value
3.63
Quarterly Volatility
319.19511788
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Amneal Pharmaceuticals, financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Amneal Pharmaceuticals,'s main balance sheet or income statement drivers, such as Depreciation And Amortization of 154.9 M, Interest Expense of 254.3 M or Selling General Administrative of 281.2 M, as well as many indicators such as Price To Sales Ratio of 0.48, Dividend Yield of 0.096 or PTB Ratio of 50.74. Amneal financial statements analysis is a perfect complement when working with Amneal Pharmaceuticals, Valuation or Volatility modules.
  
Check out the analysis of Amneal Pharmaceuticals, Correlation against competitors.

Latest Amneal Pharmaceuticals,'s Pfcf Ratio Growth Pattern

Below is the plot of the Pfcf Ratio of Amneal Pharmaceuticals, Class over the last few years. It is Amneal Pharmaceuticals,'s PFCF Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Amneal Pharmaceuticals,'s overall financial position and show how it may be relating to other accounts over time.
Pfcf Ratio10 Years Trend
Slightly volatile
   Pfcf Ratio   
       Timeline  

Amneal Pfcf Ratio Regression Statistics

Arithmetic Mean(250.87)
Coefficient Of Variation(127.23)
Mean Deviation296.86
Median(6.65)
Standard Deviation319.20
Sample Variance101,886
Range663
R-Value0.86
Mean Square Error27,931
R-Squared0.74
Significance0.000017
Slope57.83
Total Sum of Squares1.5M

Amneal Pfcf Ratio History

2025 3.63
2024 3.46
2023 3.84
2022 -11.78
2021 3.77
2020 2.15
2019 -6.65

About Amneal Pharmaceuticals, Financial Statements

Amneal Pharmaceuticals, investors use historical fundamental indicators, such as Amneal Pharmaceuticals,'s Pfcf Ratio, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Amneal Pharmaceuticals,. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
PFCF Ratio 3.46  3.63 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Amneal Stock Analysis

When running Amneal Pharmaceuticals,'s price analysis, check to measure Amneal Pharmaceuticals,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amneal Pharmaceuticals, is operating at the current time. Most of Amneal Pharmaceuticals,'s value examination focuses on studying past and present price action to predict the probability of Amneal Pharmaceuticals,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amneal Pharmaceuticals,'s price. Additionally, you may evaluate how the addition of Amneal Pharmaceuticals, to your portfolios can decrease your overall portfolio volatility.